- Home
- TUSK vs LXRX Comparison
TUSK vs LXRX Comparison
Compare TUSK & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TUSK
- LXRX
- Stock Information
- Founded
- TUSK 2014
- LXRX 1995
- Country
- TUSK United States
- LXRX United States
- Employees
- TUSK N/A
- LXRX N/A
- Industry
- TUSK Oilfield Services/Equipment
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- TUSK Energy
- LXRX Health Care
- Exchange
- TUSK Nasdaq
- LXRX Nasdaq
- Market Cap
- TUSK 128.0M
- LXRX 124.4M
- IPO Year
- TUSK 2016
- LXRX 2000
- Fundamental
- Price
- TUSK $2.49
- LXRX $0.70
- Analyst Decision
- TUSK
- LXRX Buy
- Analyst Count
- TUSK 0
- LXRX 4
- Target Price
- TUSK N/A
- LXRX $3.67
- AVG Volume (30 Days)
- TUSK 255.4K
- LXRX 5.7M
- Earning Date
- TUSK 05-07-2025
- LXRX 05-13-2025
- Dividend Yield
- TUSK N/A
- LXRX N/A
- EPS Growth
- TUSK N/A
- LXRX N/A
- EPS
- TUSK N/A
- LXRX N/A
- Revenue
- TUSK $207,208,000.00
- LXRX $31,081,000.00
- Revenue This Year
- TUSK N/A
- LXRX N/A
- Revenue Next Year
- TUSK $28.22
- LXRX $84.78
- P/E Ratio
- TUSK N/A
- LXRX N/A
- Revenue Growth
- TUSK N/A
- LXRX 2481.48
- 52 Week Low
- TUSK $1.68
- LXRX $0.28
- 52 Week High
- TUSK $4.94
- LXRX $2.45
- Technical
- Relative Strength Index (RSI)
- TUSK 50.94
- LXRX 60.07
- Support Level
- TUSK $2.36
- LXRX $0.63
- Resistance Level
- TUSK $2.81
- LXRX $0.71
- Average True Range (ATR)
- TUSK 0.22
- LXRX 0.07
- MACD
- TUSK -0.02
- LXRX -0.00
- Stochastic Oscillator
- TUSK 28.89
- LXRX 55.00
About TUSK Mammoth Energy Services Inc.
Mammoth Energy Services Inc is an integrated energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. The company had three reportable segments, which includes well completion services (Well Completion), infrastructure services (Infrastructure) and natural sand proppant services (Sand). Key revenue is generated from Infrastructure which include electric utility infrastructure services to government-funded utilities, private utilities, public investor-owned utilities, etc.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.